AXSM in the 13F filings
Axsome Therapeutics Inc · CUSIP 05464T104
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 34
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 11 listed it in both
- Shares listed
- 9,193,953
- combined, among listed positions
- Reported value
- $2.2bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 24 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,049,669.
Managers listing AXSM in Q2 2026
34 of 34 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 556,088 shares now+535,330
- Jane Street Group LLCexisting position · 403,995 shares now+399,917
- Invesco Ltdexisting position · 1,671,684 shares now+374,006
- Two Sigma Investments LPexisting position · 669,478 shares now+346,700
- Arrowstreet Capital LPnew position · 135,195 shares now+135,195
Reductions
- T. Rowe Price Associates Incexisting position · 642,893 shares now-674,166
- Wellington Management Group LLPexisting position · 653,920 shares now-491,386
- Man Group PLCexisting position · 82,526 shares now-59,745
- Walleye Capital LLCexisting position · 1,716 shares now-33,403
- Fidelity (FMR LLC)existing position · 1,539,163 shares now-27,832
New positions and exits
New (7)
Exited (3)
- ExodusPoint Capital Management LPwas $3.0m
- Farallon Capital Management LLCwas $676k
- Freestone Grove Partners LPwas $319k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2017 | 1 | $338k | n.a. | n.a. |
| Q3 2018 | 1 | $62k | n.a. | n.a. |
| Q1 2019 | 2 | $2.7m | n.a. | n.a. |
| Q2 2019 | 2 | $16m | n.a. | n.a. |
| Q3 2019 | 2 | $11m | n.a. | n.a. |
| Q4 2019 | 7 | $162m | n.a. | n.a. |
| Q1 2020 | 5 | $48m | n.a. | n.a. |
| Q2 2020 | 3 | $26m | n.a. | n.a. |
| Q3 2020 | 1 | $2.1m | n.a. | n.a. |
| Q1 2021 | 1 | $2.5m | n.a. | n.a. |
| Q3 2021 | 2 | $12m | n.a. | n.a. |
| Q1 2022 | 2 | $12m | n.a. | n.a. |
| Q2 2022 | 1 | $2.6m | n.a. | n.a. |
| Q3 2022 | 2 | $37m | n.a. | n.a. |
| Q4 2022 | 4 | $75m | n.a. | n.a. |
| Q1 2023 | 4 | $146m | n.a. | n.a. |
| Q2 2023 | 6 | $92m | n.a. | n.a. |
| Q3 2023 | 4 | $78m | n.a. | n.a. |
| Q4 2023 | 4 | $120m | 3 | 2 |
| Q1 2024 | 3 | $59m | 0 | 2 |
| Q2 2024 | 4 | $65m | 2 | 1 |
| Q3 2024 | 6 | $86m | 4 | 1 |
| Q4 2024 | 3 | $38m | 2 | 0 |
| Q1 2025 | 9 | $222m | 7 | 1 |
| Q2 2025 | 7 | $139m | 6 | 2 |
| Q3 2025 | 5 | $284m | 3 | 3 |
| Q4 2025 | 12 | $806m | 15 | 12 |
| Q1 2026 | 12 | $708m | 18 | 14 |
| Q2 2026 | 17 | $1.4bn | 24 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AXSM and LLY →AXSM and JNJ →AXSM and VRTX →Choose a stock to compare with AXSM →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AXSM, latest filings →Back to the 13F Explorer →